Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a non-profit organization that assists patients without adequate financial resources and prescription coverage obtain free products donated by Johnson & Johnson operating companies.
The Foundation is an independent organization reflecting the Johnson & Johnson operating companies’ long-standing commitment to helping patients access medicines.
Donor Companies
- Janssen Biotech, Inc.
- Janssen Pharmaceuticals, Inc.
- Janssen Therapeutics, Division of Janssen Products, LP
- DePuy Synthes Mitek Sports Medicine, a division of DePuy Orthopaedics, Inc.
Therapies Offered
-
AXERT® (almotriptan malate) Tablets
-
CONCERTA® (methylphenidate HCI) Extended-Release Tablets CII
-
DARZALEX™ (daratumumab) Injection for intravenous infusion
-
DOXIL® (doxorubicin HCl liposome) IV Infusion
-
DURAGESIC® (fentanyl) Transdermal System CII
-
EDURANT® (rilpivirine) Tablets
-
ELMIRON® (pentosan polysulfate sodium) Capsules
-
HALDOL® (haloperidol) Immediate-Release Formulation Injection
-
HALDOL® Decanoate (haloperidol) IM Injection Only
-
IMBRUVICA® (ibrutinib) Capsules
-
INTELENCE® (etravirine) Tablets
-
INVEGA TRINZA™ (paliperidone palmitate) Extended-Release Injectable Suspension
-
INVEGA® (paliperidone) Extended-Release Tablets
-
INVEGA® SUSTENNA® (paliperidone palmitate) Extended-Release Injectable Suspension
-
INVOKAMET™ (canagliflozin/metformin HCI) Tablets
-
INVOKANA® (canagliflozin) Tablets
-
LEVAQUIN® (levofloxacin) Tablets/Oral Solution
-
MONOVISC™ (high molecular weight hyaluronan) Injection
-
OLYSIO® (simeprevir) Capsules
-
ORTHOVISC® (high molecular weight hyaluronan) Injection
-
PANCREAZE® (pancrelipase) Delayed-Release Capsules
-
PREZCOBIX™ (darunavir 800mg/cobicistat 150mg) Tablets
-
PREZISTA® (darunavir) Tablets/Oral Suspension
-
PROCRIT® (epoetin alfa) Injection
-
RAZADYNE® (galantamine HBr) Tablets/Oral Solution
-
RAZADYNE® ER (galantamine HBr) Extended-Release Capsules
-
REMICADE® (infliximab) for IV Injection
-
RISPERDAL® (risperidone) M-TAB® Orally Disintegrating Tablets
-
RISPERDAL® (risperidone) Tablets/Oral Solution
-
RISPERDAL® CONSTA® (risperidone) Long-Acting Injection
-
SIMPONI® (golimumab) Injection
-
SIMPONI® ARIA™ (golimumab) IV Infusion
-
SPORANOX® (itraconazole) Capsules
-
SPORANOX® (itraconazole) Oral Solution
-
STELARA® (ustekinumab) Injection
-
SYLVANT™ (siltuximab) Infusion
-
TOPAMAX® (topiramate capsules) Sprinkle Capsules
-
TOPAMAX® (topiramate) Tablets
-
XARELTO® (rivaroxaban) Tablets
-
YONDELIS® (trabectedin) Injection for intravenous infusion
-
ZYTIGA® (abiraterone acetate) Tablets
The information provided on this page was provided by the Johnson & Johnson Patient Assistance Foundation, Inc. For information about specific prescription drugs, including the FDA-approved prescribing information, please visit Janssen Biotech, Inc. at https://www.janssenbiotech.com/our-products, Janssen Pharmaceuticals, Inc. at http://www.janssenpharmaceuticalsinc.com/our-products/product-list, Janssen Therapeutics, Division of Janssen Products, LP at http://www.janssentherapeutics.com/our-products, and DePuy Synthes Mitek Sports Medicine, a division of DePuy Orthopaedics, Inc. at https://www.depuysynthes.com/hcp/mitek-sports-medicine/products.